Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness of Narrative Exposure Therapy Among Refugee Children and Adolescents

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02425280
Recruitment Status : Completed
First Posted : April 23, 2015
Last Update Posted : October 17, 2018
Sponsor:
Information provided by (Responsible Party):
Kirsi Peltonen, Tampere University

Brief Summary:
This study aims to understand how war trauma affects children's and adolescents' memory functions and mental health, and whether Narrative Exposure Therapy is effective in enhancing optimal memory functions and alleviating mental health problems. The study analyzes the mental health and cognitive and emotional healing mechanisms of therapeutic intervention among war-affected children and adolescents.

Condition or disease Intervention/treatment Phase
Narrative Exposure Therapy Treatment as Usual Behavioral: Narrative Exposure Therapy Behavioral: Treatment as Usual Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: How to Help War-affected Children and Adolescents: the Role of Memory Functions in Therapeutic Intervention
Actual Study Start Date : November 2014
Actual Primary Completion Date : April 2018
Actual Study Completion Date : April 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Memory

Arm Intervention/treatment
Experimental: Narrative Exposure Therapy
For the intervention group receiving Narrative Exposure Therapy treatment, the intervention will last for approximately three months and include 10-12 weekly sessions of 60-90 minutes. The course of the intervention will follow the NET manual (Schauer et al., 2011).
Behavioral: Narrative Exposure Therapy
Active Comparator: Treatment as Usual
For the TAU control group, participants will receive the usual care for posttraumatic stress symptoms currently offered by each unit.
Behavioral: Treatment as Usual



Primary Outcome Measures :
  1. Post-traumatic Stress as measured by Revised Impact of Event Scale [ Time Frame: 9 months ]
  2. Depression as measured by Depression Self-Rating Scale for Children [ Time Frame: 9 months ]
  3. Psychological Distress as measured by Strengths and Difficulties Questionnaire [ Time Frame: 9 months ]
  4. Resilience as measured by Child and Youth Resilience Measure [ Time Frame: 9 months ]
  5. Cognitive Performance as measured by Working Memory Test Battery for Children [ Time Frame: 9 months ]

Secondary Outcome Measures :
  1. Quality of Traumatic Memory as measured by Trauma Memory Quality Questionnaire [ Time Frame: 9 months ]
  2. Trauma Related Cognitions as measured by Children's Post Traumatic Cognitions Inventory [ Time Frame: 9 months ]
  3. General functioning of autobiographical memory as measured by reported life events [ Time Frame: 9 months ]

Other Outcome Measures:
  1. Subjective distress during therapy measured by Subjective Units of Distress Scale [ Time Frame: 9 months ]
  2. Peritraumatic Dissociation measured by Peritraumatic Dissociative Experiences Questionnaire [ Time Frame: once, at baseline ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   9 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 9-17 years old
  • has spent some part of her/his life living in a country where organized violence was taking place, or at a refugee camp
  • suffers from significant stress symptoms thought be trauma-related

Exclusion Criteria:

  • acute psychosis
  • intellectual disability

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02425280


Locations
Layout table for location information
Finland
Centre for Torture Survivors
Helsinki, Finland
Family Counselling Centre of the City of Tampere
Tampere, Finland
Psychiatric Clinic for Traumatized Children at Tampere University Hospital
Tampere, Finland
Sponsors and Collaborators
Tampere University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Kirsi Peltonen, Postdoctoral Researcher, Tampere University
ClinicalTrials.gov Identifier: NCT02425280     History of Changes
Other Study ID Numbers: 275804
First Posted: April 23, 2015    Key Record Dates
Last Update Posted: October 17, 2018
Last Verified: October 2018